Correction

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men

N Engl J Med 1997; 337:356July 31, 1997

Article

Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men (Original Article, N Engl J Med 1997:336;973 - 979) . On page 974, the sentence that begins in line 13 under the heading “Laboratory Analysis” should have read, “The C-reactive protein assay was standardized according to the WHO First International Reference Standard and had a sensitivity of 0.08 μg per milliliter,” not “0.08 μg per microliter,” as printed.

Citing Articles (4)

Citing Articles

1. 1

   Ammar Jesri, Eni C. Okonofua, Brent M. Egan. (2005) Platelet and White Blood Cell Counts Are Elevated in Patients With the Metabolic Syndrome. The Journal of Clinical Hypertension 7:12, 705-711
   CrossRef

2. 2

   Peter A McCullough. (2004) Cardiovascular disease in chronic kidney disease from a cardiologist??s perspective. Current Opinion in Nephrology and Hypertension 13:6, 591
   CrossRef

3. 3

   David C Crossman. (2001) Opportunities for the treatment of inflammation in cardiovascular disease. Expert Opinion on Pharmacotherapy 2:11, 1751-1763
   CrossRef

4. 4

   Robert C. Kaplan, William H. Frishman. (2001) Systemic Inflammation as a Cardiovascular Disease Risk Factor and as a Potential Target for Drug Therapy. Heart Disease326-332
   CrossRef